Baxter Theranova: More Middle Molecules, Less Albumin Loss
Baxter’s new dialyzer mimics the function of natural kidneys more closely, removing more middle molecules with no replacement fluid needed—and minimal loss of vital albumin. The new expanded hemodialysis (HDx) therapy has been tested in the UK, where it reduced beta-2 microglobulin levels by more than 11%
Read the full article » | Posted 12/14/2017
Related Articles
- FDA Approves First Surgery-Free HD Access System Posted 09/10/2018
- Quanta Nears UK Launch Posted 09/10/2018
- KidneyX Funding Legislation Proposed in WA State Posted 09/10/2018
- Outset Gets One Step Closer Posted 09/10/2018
- A WAK-y Dream Coming True? Posted 07/13/2018